McKesson Profit Margin 2010-2025 | MCK

Current and historical gross margin, operating margin and net profit margin for McKesson (MCK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. McKesson net profit margin as of March 31, 2025 is 0.92%.
McKesson Annual Profit Margins
McKesson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $90.020B $359.051B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Labcorp (LH) United States $20.839B 16.90
Straumann Holding AG (SAUHY) Switzerland $20.586B 0.00
West Pharmaceutical Services (WST) United States $15.149B 31.75
Cooper (COO) United States $13.655B 17.60
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
CONMED (CNMD) United States $1.756B 13.14
STAAR Surgical (STAA) United States $0.882B 0.00
Lifevantage (LFVN) United States $0.164B 16.95
Pro-Dex (PDEX) United States $0.131B 14.30